F.D.A. Expands Access to Clozapine, a Key Treatment for Schizophrenia
Federal regulators will no longer require patients to provide blood [...]
Federal regulators will no longer require patients to provide blood [...]
Progress cannot occur if scientists are barred from asking certain [...]
The fallout from the F.D.A.’s rejection of a new treatment [...]
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to [...]
The decision will further broaden the use of the blockbuster [...]
Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization [...]
Consumer and food safety groups have long urged the agency [...]
Researchers identified one key breakthrough for GLP-1 drugs in the [...]
While some agree with Robert F. Kennedy Jr. that the [...]
The agency recommended that the maker of Librela update its [...]